A phase 2 trial of MRTX849 in combination with pembrolizumab in patients with advanced non-small cell lung cancer with KRAS G12C mutation Meeting Abstract
| Authors: | Spira, A.; Riely, G.; Lawler, W.; Shum, M.; Socinski, M.; Yanagihara, R.; Roshan, S.; Kheoh, T.; Christensen, J.; Chao, R.; Janne, P.; Garassino, M. |
| Abstract Title: | A phase 2 trial of MRTX849 in combination with pembrolizumab in patients with advanced non-small cell lung cancer with KRAS G12C mutation |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | kras; pd-1 combination; mrtx849 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S695 |
| End Page: | S696 |
| Language: | English |
| ACCESSION: | WOS:000631349602094 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.1285 |
| Notes: | Meeting Abstract: P90.03 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
